首页 > 最新文献

Interventions in Obesity & Diabetes最新文献

英文 中文
Estimated Prevalence of Advanced Hepatic Fibrosis by Elastography in Patients with Type 2 Diabetes 用弹性成像估计2型糖尿病患者晚期肝纤维化的患病率
Pub Date : 2020-02-20 DOI: 10.31031/IOD.2020.03.000570
Y. Sumida, Masashi Yoneda, K. Tokushige, M. Kawanaka, H. Fujii, M. Yoneda, Kento Imajo, H. Takahashi, YuichiroEguchi, M. Ono, Y. Nozaki, H. Hyogo, M. Koseki, Y. Yoshida, T. Kawaguchi, Y. Kamada, T. Okanoue, A. Nakajima
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. The grade of hepatic fibrosis is known to be closely associated with over-all or liver-related mortality in NAFLD. In order to detect early stage of hepatocellular carcinoma (HCC), it is essential to identify advanced hepatic fibrosis in NAFLD. To avoid invasive liver biopsies, several modalities have developed for evaluating hepatic fibrosis, including elastography (FibroScan and magnetic resonance elastography) and noninvasive tests (NITs) such as fibrosis-4 index and NAFLD fibrosis score. Patients with type 2 diabetes is twice at higher risk for incident HCC compared to the non-diabetic population. Although type 2 diabetes is also associated with fibrosis progression of NAFLD, the precise prevalence of advanced hepatic fibrosis in type 2 diabetes remains unknown. To detect or prevent the development of HCC in type 2 diabetes, mining patients with advanced fibrosis (stage 3/4) is important. It is estimated that approximately 17% of patients with type 2 diabetes receiving liver biopsies had advanced fibrosis. Population-based data are essential because of excluding selection bias. In this review, we review estimated prevalence of advanced hepatic fibrosis in patients with type 2 diabetes by using non-invasive elastography.
非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝病。已知肝纤维化的等级与NAFLD的总体死亡率或肝脏相关死亡率密切相关。为了早期发现肝细胞癌(HCC),有必要在NAFLD中识别晚期肝纤维化。为了避免侵入性肝活检,已经开发了几种评估肝纤维化的方法,包括弹性成像(纤维扫描和磁共振弹性成像)和非侵入性测试(NITs),如纤维化-4指数和NAFLD纤维化评分。2型糖尿病患者发生HCC的风险是非糖尿病人群的两倍。虽然2型糖尿病也与NAFLD的纤维化进展有关,但2型糖尿病晚期肝纤维化的确切患病率仍不清楚。为了检测或预防2型糖尿病中HCC的发展,发现晚期纤维化(3/4期)患者是很重要的。据估计,接受肝活检的2型糖尿病患者中约有17%患有晚期纤维化。基于人群的数据是必不可少的,因为可以排除选择偏差。在这篇综述中,我们回顾了通过无创弹性成像估计的2型糖尿病患者晚期肝纤维化的患病率。
{"title":"Estimated Prevalence of Advanced Hepatic Fibrosis by Elastography in Patients with Type 2 Diabetes","authors":"Y. Sumida, Masashi Yoneda, K. Tokushige, M. Kawanaka, H. Fujii, M. Yoneda, Kento Imajo, H. Takahashi, YuichiroEguchi, M. Ono, Y. Nozaki, H. Hyogo, M. Koseki, Y. Yoshida, T. Kawaguchi, Y. Kamada, T. Okanoue, A. Nakajima","doi":"10.31031/IOD.2020.03.000570","DOIUrl":"https://doi.org/10.31031/IOD.2020.03.000570","url":null,"abstract":"Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. The grade of hepatic fibrosis is known to be closely associated with over-all or liver-related mortality in NAFLD. In order to detect early stage of hepatocellular carcinoma (HCC), it is essential to identify advanced hepatic fibrosis in NAFLD. To avoid invasive liver biopsies, several modalities have developed for evaluating hepatic fibrosis, including elastography (FibroScan and magnetic resonance elastography) and noninvasive tests (NITs) such as fibrosis-4 index and NAFLD fibrosis score. Patients with type 2 diabetes is twice at higher risk for incident HCC compared to the non-diabetic population. Although type 2 diabetes is also associated with fibrosis progression of NAFLD, the precise prevalence of advanced hepatic fibrosis in type 2 diabetes remains unknown. To detect or prevent the development of HCC in type 2 diabetes, mining patients with advanced fibrosis (stage 3/4) is important. It is estimated that approximately 17% of patients with type 2 diabetes receiving liver biopsies had advanced fibrosis. Population-based data are essential because of excluding selection bias. In this review, we review estimated prevalence of advanced hepatic fibrosis in patients with type 2 diabetes by using non-invasive elastography.","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"151 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121387975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Artificial Intelligence Techniques as Potential Tools for Large Scale Surveillance and Interventions for Obesity 人工智能技术作为大规模监测和干预肥胖的潜在工具
Pub Date : 2020-02-19 DOI: 10.31031/IOD.2020.03.000569
Alice Guo, Min Jiang
Obesity and diabetes are two metabolic disorder diseases, which are strictly correlated. The diagnosis and surveillance of obesity is crucial for public health management, policy making, and interventions. Current practices are mainly based on individuals’ visits to hospitals or clinics to get the measurement and diagnosis for obesity and diabetes, or with telephone calls and personal interviews for surveillance. We advocate that with advances in artificial intelligence (AI), there is great potential to perform obesity diagnosis and surveillance with AI technologies. The key approaches are based on taking pictures or photos of human faces or bodies by using camera sensors, performing computational analysis of the photos, and obtaining the body mass index (BMI) estimation. These AI technologies make it possible to accomplish a large scale diagnosis and monitoring of public health conditions. Furthermore, these technologies also make it possible for interventions with large populations, aided by Internet connections and smart phones for communications. In this article, the aforementioned idea is presented with a brief overview and summary of the currently available AI technologies, opening a window for an innovative way to perform diagnosis, surveillance, and interventions for obesity.
肥胖与糖尿病是两种代谢性疾病,两者之间有着密切的关系。肥胖的诊断和监测对公共卫生管理、政策制定和干预措施至关重要。目前的做法主要是通过个人到医院或诊所进行肥胖和糖尿病的测量和诊断,或者通过电话和个人访谈进行监测。我们主张,随着人工智能(AI)的进步,利用人工智能技术进行肥胖诊断和监测具有巨大的潜力。关键方法是利用相机传感器拍摄人脸或人体的照片,对照片进行计算分析,获得身体质量指数(BMI)估算。这些人工智能技术使大规模诊断和监测公共卫生状况成为可能。此外,在互联网连接和智能电话的帮助下,这些技术还使对大量人口的干预成为可能。在这篇文章中,上述的想法是通过对当前可用的人工智能技术的简要概述和总结来提出的,为一种创新的方式来进行肥胖的诊断、监测和干预打开了一扇窗。
{"title":"Artificial Intelligence Techniques as Potential Tools for Large Scale Surveillance and Interventions for Obesity","authors":"Alice Guo, Min Jiang","doi":"10.31031/IOD.2020.03.000569","DOIUrl":"https://doi.org/10.31031/IOD.2020.03.000569","url":null,"abstract":"Obesity and diabetes are two metabolic disorder diseases, which are strictly correlated. The diagnosis and surveillance of obesity is crucial for public health management, policy making, and interventions. Current practices are mainly based on individuals’ visits to hospitals or clinics to get the measurement and diagnosis for obesity and diabetes, or with telephone calls and personal interviews for surveillance. We advocate that with advances in artificial intelligence (AI), there is great potential to perform obesity diagnosis and surveillance with AI technologies. The key approaches are based on taking pictures or photos of human faces or bodies by using camera sensors, performing computational analysis of the photos, and obtaining the body mass index (BMI) estimation. These AI technologies make it possible to accomplish a large scale diagnosis and monitoring of public health conditions. Furthermore, these technologies also make it possible for interventions with large populations, aided by Internet connections and smart phones for communications. In this article, the aforementioned idea is presented with a brief overview and summary of the currently available AI technologies, opening a window for an innovative way to perform diagnosis, surveillance, and interventions for obesity.","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121027159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antidiabetic Treatments for Diabetes with Liver Cirrhosis 糖尿病合并肝硬化的降糖治疗
Pub Date : 2020-02-11 DOI: 10.31031/IOD.2020.03.000566
Y. Sumida, M. Yoneda, K. Tokushige, M. Kawanaka, H. Fujii, M. Yoneda, Kento Imajo, H. Takahashi, YuichiroEguchi, M. Ono, Y. Nozaki, H. Hyogo, M. Koseki, Y. Yoshida, T. Kawaguchi, Y. Kamada, T. Okanoue, A. Nakajima
Diabetes is associated with about 30% of liver cirrhosis and affects prognosis, carcinogenesis, and the onset of complications. In cirrhosis, fasting normal and postprandial hyperglycemia are often present, and evaluation by glucose tolerance test or continuous blood glucose measurement is also considered. Although no treatment strategy has been established, if renal function is maintained, metformin will be the first choice, but for renal dysfunction cases and metformin ineffective cases, insulin will be indicated. Although the efficacy and safety of incretin-related drugs and sodium-glucose cotransporter 2 inhibitors have not been established, they can be expected to be effective in cases with obesity. On the viewpoint of preventing sarcopenia and hepatocarcinogenesis, antidiabetic drugs should be selected. Exogenous insulin should be indicated for patients with Child C grade. This review discusses antidiabetic treatments for diabetes with liver cirrhosis.
糖尿病与约30%的肝硬化有关,并影响预后、癌变和并发症的发生。肝硬化常伴有空腹正常和餐后高血糖,也可考虑通过糖耐量试验或连续血糖测量进行评价。虽然目前还没有确定治疗策略,但在维持肾功能的情况下,二甲双胍将是首选,但对于肾功能不全和二甲双胍无效的病例,将会考虑胰岛素治疗。虽然肠促胰岛素相关药物和钠-葡萄糖共转运蛋白2抑制剂的有效性和安全性尚未确定,但可以预期它们对肥胖患者有效。从预防肌肉减少和肝癌发生的角度出发,选择降糖药物。外源性胰岛素应适用于儿童C级患者。本文就糖尿病合并肝硬化的降糖治疗进行综述。
{"title":"Antidiabetic Treatments for Diabetes with Liver Cirrhosis","authors":"Y. Sumida, M. Yoneda, K. Tokushige, M. Kawanaka, H. Fujii, M. Yoneda, Kento Imajo, H. Takahashi, YuichiroEguchi, M. Ono, Y. Nozaki, H. Hyogo, M. Koseki, Y. Yoshida, T. Kawaguchi, Y. Kamada, T. Okanoue, A. Nakajima","doi":"10.31031/IOD.2020.03.000566","DOIUrl":"https://doi.org/10.31031/IOD.2020.03.000566","url":null,"abstract":"Diabetes is associated with about 30% of liver cirrhosis and affects prognosis, carcinogenesis, and the onset of complications. In cirrhosis, fasting normal and postprandial hyperglycemia are often present, and evaluation by glucose tolerance test or continuous blood glucose measurement is also considered. Although no treatment strategy has been established, if renal function is maintained, metformin will be the first choice, but for renal dysfunction cases and metformin ineffective cases, insulin will be indicated. Although the efficacy and safety of incretin-related drugs and sodium-glucose cotransporter 2 inhibitors have not been established, they can be expected to be effective in cases with obesity. On the viewpoint of preventing sarcopenia and hepatocarcinogenesis, antidiabetic drugs should be selected. Exogenous insulin should be indicated for patients with Child C grade. This review discusses antidiabetic treatments for diabetes with liver cirrhosis.","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133879649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Obesity Paradox in Cardiovascular Diseases and Research Progress 心血管疾病中的肥胖悖论及其研究进展
Pub Date : 2020-02-06 DOI: 10.31031/IOD.2020.03.000565
Changping Li, Lili Zhang, Zhong Chen
The World Health Organization has defined overweight and obesity based on body mass index (BMI; weight in kilograms/height in meters squared, kg/m2). The prevalence of overweight and obesity as defined by BMI is rapidly increasing, particularly in children and adolescents, and associated with significantly increased risk of CVDs at an earlier age [1]. There is scientific consensus that obesity increases the risk of CVDs, excessive body weight associated with negative effects on hemodynamics, cardiac morphology and ventricular function, even metabolically healthy obese individuals had a higher risk for coronary heart disease [2,3]. It seems different from what we imagined, despite this negative correlation, recent epidemiological data and numerous studies found that overweight and obese people with established CVDs appear to have a better clinical prognosis. It is necessary for us to face up to this problem, because it may affect our diagnosis and treatment of patients. Is patients with CVDs fatter really fitter?
世界卫生组织根据身体质量指数(BMI)定义了超重和肥胖。重量(千克)/高度(米)的平方(千克/平方米)。体重指数定义的超重和肥胖患病率正在迅速增加,特别是在儿童和青少年中,并与早期心血管疾病风险显著增加相关。科学界一致认为,肥胖会增加心血管疾病的风险,体重过重会对血流动力学、心脏形态和心室功能产生负面影响,即使是代谢健康的肥胖个体也有更高的冠心病风险[2,3]。这似乎与我们想象的不同,尽管存在负相关,但最近的流行病学数据和大量研究发现,患有心血管疾病的超重和肥胖人群似乎有更好的临床预后。我们有必要正视这个问题,因为它可能会影响我们对病人的诊断和治疗。心血管疾病患者肥胖真的更健康吗?
{"title":"Obesity Paradox in Cardiovascular Diseases and Research Progress","authors":"Changping Li, Lili Zhang, Zhong Chen","doi":"10.31031/IOD.2020.03.000565","DOIUrl":"https://doi.org/10.31031/IOD.2020.03.000565","url":null,"abstract":"The World Health Organization has defined overweight and obesity based on body mass index (BMI; weight in kilograms/height in meters squared, kg/m2). The prevalence of overweight and obesity as defined by BMI is rapidly increasing, particularly in children and adolescents, and associated with significantly increased risk of CVDs at an earlier age [1]. There is scientific consensus that obesity increases the risk of CVDs, excessive body weight associated with negative effects on hemodynamics, cardiac morphology and ventricular function, even metabolically healthy obese individuals had a higher risk for coronary heart disease [2,3]. It seems different from what we imagined, despite this negative correlation, recent epidemiological data and numerous studies found that overweight and obese people with established CVDs appear to have a better clinical prognosis. It is necessary for us to face up to this problem, because it may affect our diagnosis and treatment of patients. Is patients with CVDs fatter really fitter?","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126357353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Pediatric Obesity with Adult Cardiovascular Disease: A Narrative Review of Published Evidence 儿童肥胖与成人心血管疾病的关联:对已发表证据的述评
Pub Date : 2019-10-16 DOI: 10.31031/IOD.2019.03.000561
S. Uwaezuoke, A. Ayuk, U. Chikani, J. Eze, Adiele Kd, A. Aronu
The prevalence of pediatric obesity is increasing globally because of lifestyles, which fundamentally create an imbalance that favors caloric intake over expenditure [1]. These lifestyles include sedentary habits such as addiction to computer games, internet, and television, as well as a regular intake of energy-dense fast foods [2]. Several reports reveal the health burden of childhood and adolescent obesity in both developing and developed countries [3-9]. Whereas obesity is prevalent in the lower socio-economic class in developed countries, it is more common in the upper socio-economic class in developing countries. In the latter, sedentary habits and indulgence in fast foods (nutritional transition) are regarded as signs of affluence [10]. Obesity in children and adolescents is associated with several comorbidities and complications, like hypertension [11], obstructive sleep apnea syndrome [12], orthopedic disorders [13], insulin resistance and type 2 diabetes mellitus (T2DM) [14,15], dyslipidemia [16], and malignancies [17]. In the pediatric cardio-metabolic syndrome, genetic and environmental factors synergistically act as triggers; but obesity remains the primary etiologic factor which leads to hyperinsulinemia, and subsequently to hypertension and dyslipidemia [18]. Some authors have, however, proposed five diagnostic components for the syndrome, namely abdominal obesity (increased waist circumference), hyperglycemia (glucose intolerance), hypertriglyceridemia, low high-density lipoprotein-cholesterol (LDL-C) and hypertension [19]. More importantly, some of these diagnostic components are also putative risk factors for T2DM and adult cardiovascular diseases (CVD) such as coronary heart disease (CHD), cerebrovascular accident (CVA), heart failure, hypertensive heart disease, cardiac dysrhythmias, and thrombo-embolic disease.
由于生活方式的原因,全球儿童肥胖症的患病率正在上升,这种生活方式从根本上造成了热量摄入大于消耗的不平衡。这些生活方式包括久坐不动的习惯,比如沉迷于电脑游戏、网络和电视,以及经常摄入高能量的快餐。一些报告揭示了发展中国家和发达国家儿童和青少年肥胖的健康负担[3-9]。在发达国家,肥胖普遍存在于社会经济地位较低的阶层,而在发展中国家,肥胖在社会经济地位较高的阶层中更为普遍。在后者中,久坐不动的习惯和对快餐的放纵(营养转变)被认为是富裕的标志。儿童和青少年肥胖与多种合并症和并发症相关,如高血压[11]、阻塞性睡眠呼吸暂停综合征[12]、骨科疾病[13]、胰岛素抵抗和2型糖尿病(T2DM)[14,15]、血脂异常[16]和恶性肿瘤[17]。在小儿心脏代谢综合征中,遗传和环境因素协同作用为触发因素;但肥胖仍然是导致高胰岛素血症,进而导致高血压和血脂异常的主要病因。然而,一些作者提出了该综合征的五种诊断成分,即腹部肥胖(腰围增加)、高血糖症(葡萄糖不耐受)、高甘油三酯血症、低高密度脂蛋白胆固醇(LDL-C)和高血压。更重要的是,其中一些诊断成分也是T2DM和成人心血管疾病(CVD)如冠心病(CHD)、脑血管意外(CVA)、心力衰竭、高血压心脏病、心律失常和血栓栓塞性疾病的推定危险因素。
{"title":"Association of Pediatric Obesity with Adult Cardiovascular Disease: A Narrative Review of Published Evidence","authors":"S. Uwaezuoke, A. Ayuk, U. Chikani, J. Eze, Adiele Kd, A. Aronu","doi":"10.31031/IOD.2019.03.000561","DOIUrl":"https://doi.org/10.31031/IOD.2019.03.000561","url":null,"abstract":"The prevalence of pediatric obesity is increasing globally because of lifestyles, which fundamentally create an imbalance that favors caloric intake over expenditure [1]. These lifestyles include sedentary habits such as addiction to computer games, internet, and television, as well as a regular intake of energy-dense fast foods [2]. Several reports reveal the health burden of childhood and adolescent obesity in both developing and developed countries [3-9]. Whereas obesity is prevalent in the lower socio-economic class in developed countries, it is more common in the upper socio-economic class in developing countries. In the latter, sedentary habits and indulgence in fast foods (nutritional transition) are regarded as signs of affluence [10]. Obesity in children and adolescents is associated with several comorbidities and complications, like hypertension [11], obstructive sleep apnea syndrome [12], orthopedic disorders [13], insulin resistance and type 2 diabetes mellitus (T2DM) [14,15], dyslipidemia [16], and malignancies [17]. In the pediatric cardio-metabolic syndrome, genetic and environmental factors synergistically act as triggers; but obesity remains the primary etiologic factor which leads to hyperinsulinemia, and subsequently to hypertension and dyslipidemia [18]. Some authors have, however, proposed five diagnostic components for the syndrome, namely abdominal obesity (increased waist circumference), hyperglycemia (glucose intolerance), hypertriglyceridemia, low high-density lipoprotein-cholesterol (LDL-C) and hypertension [19]. More importantly, some of these diagnostic components are also putative risk factors for T2DM and adult cardiovascular diseases (CVD) such as coronary heart disease (CHD), cerebrovascular accident (CVA), heart failure, hypertensive heart disease, cardiac dysrhythmias, and thrombo-embolic disease.","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125221924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Screening and Counselling: Implications for Public Health as Tools for Interventions in Obesity and Diabetes 遗传筛查和咨询:作为干预肥胖和糖尿病的工具对公共卫生的影响
Pub Date : 2019-10-09 DOI: 10.31031/iod.2019.03.000560
Godwin Michael Ubi
A disease is any condition that affects the normal functioning of one or more systems in an organism. In other words, it may be described as any condition that impairs normal body function(s). Diseases are a lack of a healthy state of life, a disorder or illness caused by infections rather than by accident. Medically disease is defined as any deviation from or interruptions of the normal structure or function of any body part, organ or system that is manifested by a characteristic set of symptoms and signs and whose etiology, pathology and prognosis may be known or unknown. Disease is said to have caused over three hundred million illnesses and over five million deaths against accident and other causes of death. For being the number one killer, conquering diseases is given premium in the scale of preference of the quest to conquer nature in human search for reliable knowledge which is the core concern of scientific investigations. Diseases may be caused by several factors originating from external or exogenous sources such as microbial – related or infections diseases, or internal dysfunctions such as autoimmune diseases. Other non-infectious diseases include cancer, most heart diseases, genetic diseases such as sickle cell aneamia, albinism, down syndrome.
疾病是影响机体一个或多个系统正常功能的任何状况。换句话说,它可以被描述为任何损害正常身体功能的状况。疾病是一种缺乏健康的生活状态,是一种由感染而不是偶然引起的紊乱或疾病。医学上对疾病的定义是:任何身体部位、器官或系统的正常结构或功能的任何偏离或中断,表现为一系列特征性的症状和体征,其病因、病理和预后是已知或未知的。据说疾病造成了3亿多人生病,500多万人死于事故和其他死因。作为头号杀手,征服疾病在人类对可靠知识的探索中被赋予了优先级,而征服自然是科学研究的核心问题。疾病可由多种外部或外源性因素引起,如微生物相关或感染性疾病,或内部功能障碍,如自身免疫性疾病。其他非传染性疾病包括癌症、大多数心脏病、镰状细胞性贫血、白化病、唐氏综合症等遗传性疾病。
{"title":"Genetic Screening and Counselling: Implications for Public Health as Tools for Interventions in Obesity and Diabetes","authors":"Godwin Michael Ubi","doi":"10.31031/iod.2019.03.000560","DOIUrl":"https://doi.org/10.31031/iod.2019.03.000560","url":null,"abstract":"A disease is any condition that affects the normal functioning of one or more systems in an organism. In other words, it may be described as any condition that impairs normal body function(s). Diseases are a lack of a healthy state of life, a disorder or illness caused by infections rather than by accident. Medically disease is defined as any deviation from or interruptions of the normal structure or function of any body part, organ or system that is manifested by a characteristic set of symptoms and signs and whose etiology, pathology and prognosis may be known or unknown. Disease is said to have caused over three hundred million illnesses and over five million deaths against accident and other causes of death. For being the number one killer, conquering diseases is given premium in the scale of preference of the quest to conquer nature in human search for reliable knowledge which is the core concern of scientific investigations. Diseases may be caused by several factors originating from external or exogenous sources such as microbial – related or infections diseases, or internal dysfunctions such as autoimmune diseases. Other non-infectious diseases include cancer, most heart diseases, genetic diseases such as sickle cell aneamia, albinism, down syndrome.","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126096375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diabetes, Obesity and Atherosclerosis: Three Buds of One Stem MS-X 糖尿病、肥胖和动脉粥样硬化:一茎三芽MS-X
Pub Date : 2019-09-16 DOI: 10.31031/iod.2019.03.000559
N. Chandra
Ideally insulin and leptin signaling share a common route and ditch each other depending on their surge in their affected physiological state. As a result, insulin and leptin resistances are simultaneous phenomena and no matter to induce other while the one is precipitated. Thus, the preponderance of running obesity and type-2 diabetes hand to hand is deeply expected. The (Figure 2) shows the common signaling road of both the ligands. Report shows that obesity reduces tyrosine phosphorylation of insulin receptor [12]. This affects insulin signaling and hence initiates insulin resistance. On the other hand, report also shows an association of insulin and LDL receptors [12-15] and this association keeps LDL receptor non-functional [12-15] making the system prone to vessel LDL accumulation. Yadav et al. has shown a decrease of LDL receptor mRNA level with increase of leptin concentration as well as two receptor association [14]. Repressed LDL receptor will reduce LDL clearance from blood vessels and the receptor-complex will keep receptors non-functional with concomitant Crimson Publishers Wings to the Research Mini Review
理想情况下,胰岛素和瘦素信号共享一条共同的途径,并根据它们受影响的生理状态的激增而相互抛弃。因此,胰岛素抵抗和瘦素抵抗是同时发生的现象,一方沉淀,另一方诱导。因此,跑步型肥胖和2型糖尿病的优势是可以预见的。(图2)显示了这两种配体的共同信号通路。有报道表明,肥胖可降低胰岛素受体酪氨酸磷酸化[12]。这会影响胰岛素信号传导,从而引发胰岛素抵抗。另一方面,也有报道显示胰岛素和LDL受体存在关联[12-15],这种关联使LDL受体失去功能[12-15],使系统易于血管LDL积累。Yadav等研究表明,LDL受体mRNA水平随着瘦素浓度的升高而降低,两受体存在关联[14]。受抑制的LDL受体将减少LDL从血管中的清除,受体复合物将使受体失去功能
{"title":"Diabetes, Obesity and Atherosclerosis: Three Buds of One Stem MS-X","authors":"N. Chandra","doi":"10.31031/iod.2019.03.000559","DOIUrl":"https://doi.org/10.31031/iod.2019.03.000559","url":null,"abstract":"Ideally insulin and leptin signaling share a common route and ditch each other depending on their surge in their affected physiological state. As a result, insulin and leptin resistances are simultaneous phenomena and no matter to induce other while the one is precipitated. Thus, the preponderance of running obesity and type-2 diabetes hand to hand is deeply expected. The (Figure 2) shows the common signaling road of both the ligands. Report shows that obesity reduces tyrosine phosphorylation of insulin receptor [12]. This affects insulin signaling and hence initiates insulin resistance. On the other hand, report also shows an association of insulin and LDL receptors [12-15] and this association keeps LDL receptor non-functional [12-15] making the system prone to vessel LDL accumulation. Yadav et al. has shown a decrease of LDL receptor mRNA level with increase of leptin concentration as well as two receptor association [14]. Repressed LDL receptor will reduce LDL clearance from blood vessels and the receptor-complex will keep receptors non-functional with concomitant Crimson Publishers Wings to the Research Mini Review","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129875877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interplay of Nutrients and Muscle Myokines on the Preventive Health for Obesity Disorders 营养物质和肌肉肌肉因子在肥胖疾病预防保健中的相互作用
Pub Date : 2019-09-04 DOI: 10.31031/iod.2019.03.000558
R. K. Venkata, Praveen
Physical exercise seems to be an effective tool in enhancing the functional health of the various systems of the body and the consequent health status of individuals. Physical inactivity could foster for flaring up of inflammatory mechanisms that might affect different tissues negatively and could lead to severe debilitating health conditions. Though the physical exercise could play pivotal role in securing the preventive health, the science of disease reiterates that there seems a systematic inter connectivity among molecular responses that make the bioenvironment so dynamic, may respond differently and or in inter-connected manner to several epigenetic factors like exercise, nutrition, stress, environment etc. and could show rhetoric impact on the genetic expression, thereby influencing the preventive health of individuals. This rhetoric explains the need of studying the interactive epigenetic effects and consequent responses. Muscle secretum consisting of myocytes, myotubules and other skeletal muscle tissue environment produces cytokine like substances called myokines, that may initiate the cross talk among the various tissues of the body acting in autocrine, paracrine and endocrine manner. Several hundreds of such myokines are identified by researchers and attributed with different functions through the control of the signaling cascades of the metabolism. Some myokines may act directly as signaling molecules while some other are seen as co-factors for other signaling molecules thereby effecting changes in the bioenvironment of the individuals. These exercise factors may be released by the skeletal muscles differently depending on the intensity, duration and type of exercise undertaken. Aerobic and anaerobic exercises undertaken at different intensities cause for the secretion of different myokines which might bring different signaling effects and cause for different changes. Hence, aerobic running might cause for the secretion of certain types of myokines whereas the high intensity anaerobic running could cause for certain other myokine secretion. Resistance training showed different myokines released from the skeletal muscle. The physiology of muscle fibers may also influence the type of myokine secretion and its quality. Different muscle fibers may cause to produce different myokines. Exercise has an innate effect that would foster bioenvironment so favorably, to equip higher readiness for the next bout of exercise program by bringing several super compensation effects. These super compensation effects of exercise may be brought by the secretion of myokines which would influence the metabolic cascades for the above purpose. Higher exercise potential of the individuals may be achieved through regular bouts of physical training that is conducted very scientifically that would cause for several physiological changes. The readiness for higher exercise potential indicates the higher functional health of the different organs of the body and this
体育锻炼似乎是一种有效的工具,可以增强身体各系统的功能健康,从而改善个人的健康状况。缺乏运动可能会促进炎症机制的爆发,这可能会对不同的组织产生负面影响,并可能导致严重的衰弱性健康状况。虽然体育锻炼可以在确保预防性健康方面发挥关键作用,但疾病科学重申,分子反应之间似乎存在系统的相互联系,使生物环境如此动态,可能对运动,营养,压力,环境等几种表观遗传因素做出不同或相互关联的反应,并可能对基因表达产生重大影响,从而影响个人的预防性健康。这种修辞解释了研究相互作用的表观遗传效应和随之而来的反应的必要性。肌肉分泌物由肌细胞、肌小管等骨骼肌组织环境组成,产生细胞因子样物质,称为肌因子,可引发机体各组织间的自分泌、旁分泌和内分泌等交互作用。研究人员发现了数百种这样的肌肉因子,它们通过控制代谢的信号级联反应而具有不同的功能。一些肌因子可以直接作为信号分子,而另一些则被视为其他信号分子的辅助因子,从而影响个体生物环境的变化。根据运动的强度、持续时间和类型不同,骨骼肌可能会以不同的方式释放这些运动因子。不同强度的有氧和无氧运动导致不同的肌因子分泌,可能带来不同的信号作用,引起不同的变化。因此,有氧跑步可能导致某些类型的肌肉因子的分泌,而高强度的无氧跑步可能导致某些其他肌肉因子的分泌。阻力训练显示骨骼肌释放出不同的肌因子。肌纤维的生理机能也可能影响肌因子分泌的类型和质量。不同的肌肉纤维可能导致产生不同的肌肉因子。运动有一种天生的效果,它可以很好地促进生物环境,通过带来几种超级补偿效应,为下一轮运动计划做好更高的准备。运动的这些超级补偿作用可能是通过分泌肌因子来影响代谢级联反应来实现的。提高个人的运动潜力可以通过定期的体育训练来实现,这种训练是非常科学的,会引起一些生理上的变化。对更高的运动潜力的准备表明身体不同器官的功能健康程度更高,这通常伴随着个人更高的预防健康状态。这种准备可以通过增强抗炎状态、增强抗氧化状态、更好的动脉内皮恢复、增强血管生成、增加底物超补偿、增强正蛋白转换、增强葡萄糖耐量和胰岛素敏感性、增强脂解级联、增强线粒体酶反应、增强脑和激素轴以及其他一些积极作用来实现。肌因子或运动因素可能影响这些情况,通常不是单独的,而是联合的,并且由于运动计划,也可以观察到不同肌因子的释放。深红出版社的研究意见之翼
{"title":"Interplay of Nutrients and Muscle Myokines on the Preventive Health for Obesity Disorders","authors":"R. K. Venkata, Praveen","doi":"10.31031/iod.2019.03.000558","DOIUrl":"https://doi.org/10.31031/iod.2019.03.000558","url":null,"abstract":"Physical exercise seems to be an effective tool in enhancing the functional health of the various systems of the body and the consequent health status of individuals. Physical inactivity could foster for flaring up of inflammatory mechanisms that might affect different tissues negatively and could lead to severe debilitating health conditions. Though the physical exercise could play pivotal role in securing the preventive health, the science of disease reiterates that there seems a systematic inter connectivity among molecular responses that make the bioenvironment so dynamic, may respond differently and or in inter-connected manner to several epigenetic factors like exercise, nutrition, stress, environment etc. and could show rhetoric impact on the genetic expression, thereby influencing the preventive health of individuals. This rhetoric explains the need of studying the interactive epigenetic effects and consequent responses. Muscle secretum consisting of myocytes, myotubules and other skeletal muscle tissue environment produces cytokine like substances called myokines, that may initiate the cross talk among the various tissues of the body acting in autocrine, paracrine and endocrine manner. Several hundreds of such myokines are identified by researchers and attributed with different functions through the control of the signaling cascades of the metabolism. Some myokines may act directly as signaling molecules while some other are seen as co-factors for other signaling molecules thereby effecting changes in the bioenvironment of the individuals. These exercise factors may be released by the skeletal muscles differently depending on the intensity, duration and type of exercise undertaken. Aerobic and anaerobic exercises undertaken at different intensities cause for the secretion of different myokines which might bring different signaling effects and cause for different changes. Hence, aerobic running might cause for the secretion of certain types of myokines whereas the high intensity anaerobic running could cause for certain other myokine secretion. Resistance training showed different myokines released from the skeletal muscle. The physiology of muscle fibers may also influence the type of myokine secretion and its quality. Different muscle fibers may cause to produce different myokines. Exercise has an innate effect that would foster bioenvironment so favorably, to equip higher readiness for the next bout of exercise program by bringing several super compensation effects. These super compensation effects of exercise may be brought by the secretion of myokines which would influence the metabolic cascades for the above purpose. Higher exercise potential of the individuals may be achieved through regular bouts of physical training that is conducted very scientifically that would cause for several physiological changes. The readiness for higher exercise potential indicates the higher functional health of the different organs of the body and this","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115127462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron Deficiency Anemia and Diabetes Mellitus 缺铁性贫血和糖尿病
Pub Date : 2019-08-22 DOI: 10.31031/iod.2019.03.000557
Çiğdem Bozkır
Iron is necessary for various metabolic processes, including oxygen transport and storage, redox reactions, cell signaling and microbial defense. Absorption, transport and storage of iron are carefully regulated, presumably to avert potential toxic effects of free iron [1,2]. Both iron overload and iron deficiency can be detrimental to health, so iron homeostasis is essential. Although many factors that take part in iron homeostasis are known, mechanisms by which the body regulates iron stores are still being elucidated [1-3]. Also, iron absorption and homeostasis are intimately linked to the inflammatory response [4]. Iron deficiency (ID) and iron deficiency anemia (IDA) are prevalent forms of nutritional deficiency. Globally, 50% of anemia is attributed to iron deficiency [5,6]. Since the body has no means of actively excreting excess iron, a sophisticated system for iron homeostasis maintains the optimal balance between adequate dietary iron absorption and iron loss in healthy individuals. Dietary iron is absorbed in a regulated manner from the gastrointestinal tract and transported between cells bound to the protein transferrin. Systemic iron homeostasis is primarily regulated by the liver-derived peptide hormone hepcidin and by the iron exporter protein ferroprotein, while intracellular iron homeostasis is regulated by the iron-regulatory protein/iron-responsive element system. The two regulatory systems are finely coordinated [7]. This finely balanced homeostasis, however, can be readily disturbed. Iron deficiency can ensue if dietary iron intake is insufficient or if iron absorption, loss, metabolism, or body distribution become abnormal due to disease or excess blood loss. A group of international experts recently proposed the following comprehensive definition of iron deficiency: “a health-related condition in which iron availability is insufficient to meet the body’s needs and which can be present with or without anemia” [8].
铁是多种代谢过程所必需的,包括氧运输和储存、氧化还原反应、细胞信号传导和微生物防御。铁的吸收、运输和储存受到严格的调控,可能是为了避免游离铁的潜在毒性作用[1,2]。铁超载和缺铁都对健康有害,所以铁的体内平衡至关重要。虽然已知许多参与铁稳态的因素,但人体调节铁储存的机制仍在阐明[1-3]。此外,铁的吸收和体内平衡与炎症反应[4]密切相关。缺铁(ID)和缺铁性贫血(IDA)是营养缺乏的常见形式。在全球范围内,50%的贫血可归因于缺铁[5,6]。由于身体没有办法主动排出多余的铁,一个复杂的铁稳态系统在健康个体中维持适当的饮食铁吸收和铁损失之间的最佳平衡。膳食铁以一种受调节的方式从胃肠道吸收,并在与转铁蛋白结合的细胞之间运输。全身铁稳态主要由肝源肽激素hepcidin和铁输出蛋白ferroprotein调节,而细胞内铁稳态则由铁调节蛋白/铁响应元件系统调节。这两个监管体系协调得很好。然而,这种精细平衡的体内平衡很容易被破坏。如果膳食铁摄入不足,或者铁的吸收、流失、代谢或身体分布因疾病或失血过多而异常,就会出现缺铁。一组国际专家最近提出了以下缺铁的综合定义:“一种与健康有关的状况,其中铁的供应不足以满足身体的需要,可能伴有或不伴有贫血”。
{"title":"Iron Deficiency Anemia and Diabetes Mellitus","authors":"Çiğdem Bozkır","doi":"10.31031/iod.2019.03.000557","DOIUrl":"https://doi.org/10.31031/iod.2019.03.000557","url":null,"abstract":"Iron is necessary for various metabolic processes, including oxygen transport and storage, redox reactions, cell signaling and microbial defense. Absorption, transport and storage of iron are carefully regulated, presumably to avert potential toxic effects of free iron [1,2]. Both iron overload and iron deficiency can be detrimental to health, so iron homeostasis is essential. Although many factors that take part in iron homeostasis are known, mechanisms by which the body regulates iron stores are still being elucidated [1-3]. Also, iron absorption and homeostasis are intimately linked to the inflammatory response [4]. Iron deficiency (ID) and iron deficiency anemia (IDA) are prevalent forms of nutritional deficiency. Globally, 50% of anemia is attributed to iron deficiency [5,6]. Since the body has no means of actively excreting excess iron, a sophisticated system for iron homeostasis maintains the optimal balance between adequate dietary iron absorption and iron loss in healthy individuals. Dietary iron is absorbed in a regulated manner from the gastrointestinal tract and transported between cells bound to the protein transferrin. Systemic iron homeostasis is primarily regulated by the liver-derived peptide hormone hepcidin and by the iron exporter protein ferroprotein, while intracellular iron homeostasis is regulated by the iron-regulatory protein/iron-responsive element system. The two regulatory systems are finely coordinated [7]. This finely balanced homeostasis, however, can be readily disturbed. Iron deficiency can ensue if dietary iron intake is insufficient or if iron absorption, loss, metabolism, or body distribution become abnormal due to disease or excess blood loss. A group of international experts recently proposed the following comprehensive definition of iron deficiency: “a health-related condition in which iron availability is insufficient to meet the body’s needs and which can be present with or without anemia” [8].","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130627905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probiotic and Prebiotic Interventions for Obesity and Diabetes 益生菌和益生元干预肥胖和糖尿病
Pub Date : 2019-08-12 DOI: 10.31031/IOD.2019.03.000556
Rakhie Narayanan, K. Sreelekshmi, C. HoneyChandran, Keerthi Tr
Diabetes and obesity are two trending metabolic disorder which leads to major complications in all cases despite of age. Both are strictly correlated and hence called diabesity. Diet is the major factor which contributes to diabesity. The microbial diversity and number in the gut environment mainly depends on the food consumed in healthy individuals. The microflora in gut profoundly affects the host metabolism through several mechanisms. There is a significant difference between the microfloral composition in diabetic and nondiabetic people as well as obese and non-obese. High fat/carbohydrate diet always promotes the establishment of putrefying and opportunistic pathogens. Supplementation of probiotics and prebiotics is a good practice to maintain a healthier gut thereby improving the host functions. The review mainly discuss about the beneficial effects of gut flora/probiotics along with prebiotics in T1D, T2D and obesity.
糖尿病和肥胖是两种趋势代谢紊乱,无论年龄大小,都会导致主要并发症。两者是严格相关的,因此被称为糖尿病。饮食是导致糖尿病的主要因素。肠道环境中微生物的多样性和数量主要取决于健康个体所摄入的食物。肠道菌群通过多种机制深刻影响宿主代谢。糖尿病人和非糖尿病人、肥胖人和非肥胖人的肠道菌群组成存在显著差异。高脂肪/高碳水化合物饮食总是促进腐败和机会性病原体的建立。补充益生菌和益生元是保持肠道健康从而改善宿主功能的良好做法。本文主要讨论肠道菌群/益生菌以及益生元在T1D、T2D和肥胖中的有益作用。
{"title":"Probiotic and Prebiotic Interventions for Obesity and Diabetes","authors":"Rakhie Narayanan, K. Sreelekshmi, C. HoneyChandran, Keerthi Tr","doi":"10.31031/IOD.2019.03.000556","DOIUrl":"https://doi.org/10.31031/IOD.2019.03.000556","url":null,"abstract":"Diabetes and obesity are two trending metabolic disorder which leads to major complications in all cases despite of age. Both are strictly correlated and hence called diabesity. Diet is the major factor which contributes to diabesity. The microbial diversity and number in the gut environment mainly depends on the food consumed in healthy individuals. The microflora in gut profoundly affects the host metabolism through several mechanisms. There is a significant difference between the microfloral composition in diabetic and nondiabetic people as well as obese and non-obese. High fat/carbohydrate diet always promotes the establishment of putrefying and opportunistic pathogens. Supplementation of probiotics and prebiotics is a good practice to maintain a healthier gut thereby improving the host functions. The review mainly discuss about the beneficial effects of gut flora/probiotics along with prebiotics in T1D, T2D and obesity.","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"117 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134165610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Interventions in Obesity & Diabetes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1